Insider Transactions in Q4 2022 at Agios Pharmaceuticals, Inc. (AGIO)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2022
|
Sarah Gheuens Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,783
-15.13%
|
$77,924
$28.48 P/Share
|
|
Dec 28
2022
|
James William Burns Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,597
-10.9%
|
$72,716
$28.48 P/Share
|
|
Dec 23
2022
|
Sarah Gheuens Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+33.77%
|
-
|
|
Dec 23
2022
|
James William Burns Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+26.87%
|
-
|
|
Dec 06
2022
|
Sarah Gheuens Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
248
-2.68%
|
$6,944
$28.83 P/Share
|
|
Dec 02
2022
|
Sarah Gheuens Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
833
+8.25%
|
-
|
|
Oct 17
2022
|
Richa Poddar Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,485
-14.86%
|
$40,095
$27.48 P/Share
|
|
Oct 15
2022
|
Richa Poddar Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+33.35%
|
-
|